Please enable Javascript on your browser for a better experience.
The Lead Blood Test measures lead levels in blood to detect exposure or poisoning. Even small amounts of lead can harm the nervous system, kidneys, and blood cells. High levels may cause developmental delays in children, fatigue, abdominal pain, or anemia in adults. Doctors use this test to monitor workplace exposure, environmental risks, or treatment effectiveness. Results provide essential insight into toxic exposure and long-term health protection.
The OSHA Lead Blood Test evaluates lead concentration in the blood to monitor workplace exposure and ensure compliance with occupational health standards. It plays a key role in protecting workers from lead-related toxicity, supporting surveillance programs, and identifying early signs of adverse health effects. This test aids in preventing complications involving the nervous system, kidneys, and cardiovascular function.
The Lead Random Urine Test measures lead excretion to evaluate recent exposure and body burden of this toxic heavy metal. Lead can accumulate in bones, kidneys, and nervous tissue, contributing to anemia, cognitive decline, and organ damage. This test helps identify acute or ongoing exposure, monitor chelation therapy, and assess occupational or environmental risks where lead contamination may be a concern.
The Lead 24 Hour Urine Test measures lead excretion over a full day to assess exposure and potential toxicity. Elevated lead levels can signal occupational or environmental exposure, impaired renal clearance, or chronic accumulation in tissues. This test helps evaluate heavy metal burden, monitor chelation therapy, and provide critical insight into kidney function and systemic toxic effects of lead.
The Lead Micronutrient Blood Test measures lead levels in the blood to assess exposure and potential toxicity. Lead, often found in contaminated water, soil, paint, or industrial settings, can harm the brain, nervous system, kidneys, and red blood cell production. This test helps detect harmful exposure, guide treatment, and monitor health risks related to lead accumulation.
Patient must be 18 years of age or older.